RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - Sviluppo e progressione del carcinoma epatocellulare: meccanismi molecolari ed implicazioni terapeutiche
• 2 - METABOLISMO LOCALE ED ESPRESSIONE GENICA: NUOVE PROSPETTIVE IN CHIRURGIA
• 3 - CONTROLLO DEL CICLO CELLULARE DA LIGANDI DI RECETTORI NUCLEARI
• 4 - Determinanti genetici e molecolari del ruolo della COX-2 nell'aterotrombosi.
• 5 - Nuove conoscenze fisiopatologiche per nuove prospettive terapeutiche del colangiocarcinoma
• 6 - Identificazione, analisi molecolare ed attività funzionale di recettori di membrana e fattori citoplasmatici coinvolti nella crescita e differenziamento di cellule di leucemia linfatica cronica B: impatto sulla prognosi clinica.
• 7 - Il colangiocarcinoma: approccio terapeutico basato su nuove acquisizioni di biologia cellulare e molecolare.
• 8 - Studio degli effetti genomici dell'aldosterone in modelli cellulari ed in vivo.
• 9 - Nuove strategie immunomodulatorie nella Malattia di Graves: ruolo delle chemochine e delle cellule T regolatorie
• 10 - Modulazione dei meccanismi di apoptosi in corso di risposta immunitaria/infiammatoria: studio delle interazioni tra citochine della famiglia del TNF per la caratterizzazione di meccanismi molecolari e cellulari funzionali alla identificazione di nuovi target per la terapia di malattie croniche degenerative.

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • GASTROENTEROLOGIA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • ORGANIC CHEMISTRY (such compounds as the oxides, sulfides, or oxysulfides of carbon, cyanogen, phosgene, hydrocyanic acid or salts thereof C01; products obtained from layered base-exchange silicates by ion-exchange with organic compounds such as ammonium, phosphonium or sulfonium compounds or by intercalation of organic compounds C01B33/44; macromolecular compounds C08; dyes C09; fermentation products C12; fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture C12P; production of organic compounds by electrolysis or electrophoresis C25B3/00, C25B7/00)
    • STEROIDS (Seco-steroids C07C)
• HUMAN NECESSITIES
  • MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (bringing into special physical form A61J [N: mechanical aspects]; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; compounds per se C01, C07, C08, C12N; soap compositions C11D; micro-organisms per se C12N) [C0203]

Classificazione geografica

• Regione: Puglia

Bibliografia

1. Francavilla A, Vujanovic NL, Polimero L et al 1997. The in vivo effect of hepatotrophic factors augmenter liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell function. Hepatology 25:411-415.
2. Vujanovic NL, Polimeno L, Azzarone A et al 1995. Changes of liver-resident NK cell during liver regeneration in rats. J Immunol 154: 6324-6328
3. Polimeno L, Margiotta M, Marangi L et al 2000. Molecular mechanisms of augmenter of liver regeneration as immunoregulator: its effect on interferon-gmma expression in rat liver. Dig Liv Dis D32:217-225
4. Hata K, Van Thiel D, Herberman RB et al 1991. Natural Killer activity of human liver-derived lymphocytes in various liver diseases. Hepatology 14:495-503.
5. Nakamoto Y., Guidotti L.G., Kuhlen C.V., et al 1998. Immune pathogenesis of Hepatocellular carcinoma. J. Exp. Med. 188:341-350.
6. Akbar S.M.F., kajino K., Tanimoto T., et al 1999. Unique features of dendritic cells in IFN-γ transgenic mice: relevance to cancer development and therapeutic implications. Biochem. Biophys. Res. Commun. 259:294-299.
7. Castellaneta A., Di Leo A., Margiotta M., et al 2005. Role of Dendritic Cell in Liver Regeneration After Partial Hepatectomy. Dig Liv Dis 37 (1): S61
8. Ninomiya T., Akbar SMD., Masumoto T., et al 1999. Dendritic cells with immature phenotype and detective function in the peripheral blood from patients with hepatocellular carcinoma. J.Hepatology 31:323-331
9. Chen S., Akbar S.M.F, Tanimoto K., et al 2000. Absence of CD83-positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma: relevance to hepatocarcinogenesis. Cancer letters 148:49-57
10. Irie M., Homma S., Komita H., et al 2004. Inhibition of spontaneous development of liver tumors by inoculation with dendritic cells loaded with hepatocellular carcinoma cells in C3H/HeNCRJ mice. Int. J. Cancer 111:238-245.
11. Lee WC, Wang HC, Jeng LB., et al 2001. Effective treatment of small murine hepatocellular carcinoma by dendritic cells. Hepatology 34(5):896-905
12. Chisari F, Klopchin K, Moriyama T et al. 1989. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59: 1145-1156.
13. Francavilla A, Di LeoA, Eagon PK et al 1984. Regeneranting Rat Liver: Correlations between estrogen receptors localization and DNA synthesis. Gastroenterology 86:552-7.
14. Francavilla A, Eagon PK, Di Leo A et al 1984. Estrogen binding protein activity in Morris hepatoma 7777 compared with normal rat liver. Gastroenterology 86:1410-6.
15. Francavilla A, Eagon PK, Di Leo A et al 1986. Sex-hormone related fuctions in regenerating male rat liver. Gastroenterology 91:1263-70
16. Francavilla A, Polimeno L, Di Leo A et al 1989. The effect of estrogen and tamoxifen on hepatocyte proliferation in vivo and in vitro. Hepatology 9:614-620
17. Eagon PK, Francavilla A, Di Leo A et al 1991. Quantitation of estrogen and androgen receptors in HCC and adjacent normal human liver. Dig Dis Sci 36:1303-1308
18. Francavilla A, Gavaler JS, Makowka L et al 1989. Estradiol and testosteron levels in patients undergoing partial hepatectomy. A possible signal for hepatic regeneration?. Dig Dis Sci 34:818-822
19. Perrone F, Gallo C, Daniele B et al 2002. Tamoxifen in the treatment of hepatocellular carcinoma: 5-years results of the CLIP-1 multicentre randomised controlled trial. Curr Pharm Des 8:1013-1019.
20. Grimaldi C, Bleiberg H, Gay F et al 1998. Evaluation of antiandrogen theraphy in unresectable hepatocellular carcinoma: results of a European Organitation for research and treatment of cancer multicentric double-blid trial. J Clin Oncol 16:411-417
21. Liu HY, Buenafe AC, Matejuk A et al. 2002. Estrogen inhibition of EAE involves effects on dendritic cell funtion. J Neur Res 70: 238-248.
19. Bell D, Young JW, Banchereau J. 1999. Dendritic cells. Adv immunol 72: 255-324.
22. Castellaneta A., Di Leo A., De Tullio N., et al. 2005 Estrogen Treatment Impaires Hepatic Dendritic Cell Function. Dig Liv Dis 37: S36
29. Castellaneta A., Di Leo A., Margotta M., et al. Liver Regeneration, Dendritic Cells and Estrogen. Dig Liv Dis 37 (1): S63
23. Visconti R, Schepis F, Iuliano R, Pierantoni GM, Zhang L, Carlomagno F, Battaglia C, Martelli ML, Trapasso F, Santoro M, Fusco A. Cloning and molecular characterization of a novel gene strongly induced by the adenovirus E1A gene in rat thyroid cells. Oncogene. 2003; 22:1087-1097.
24. Marcantonio D, Chalifour LE, Alaoui-Jamali MA, Alpert L, Huynh HT. Cloning and characterization of a novel gene that is regulated by estrogen and is associated with mammary gland carcinogenesis. Endocrinology. 2001a;142:2409-18.
25. Marcantonio D, Chalifour LE, Alaoui-Jamali And H T Huynh MA, Alaoui-Jamali MA, Alaoui-Jamali MA, Huynh HT, Huynh HT. Steroid-sensitive gene-1 is an androgen-regulated gene expressed in prostatic smooth muscle cells in vivo. J Mol Endocrinol. 2001b;26:175-84.
26. Bommer GT, Jager C, Durr EM, Baehs S, Eichhorst ST, Brabletz T, Hu G, Frohlich T, Arnold G, Kress DC, Goke B, Fearon ER, Kolligs FT. DRO1, a gene down-regulated by oncogenes, mediates growth inhibition in colon and pancreatic cancer cells. J Biol Chem. 2005; 280:7962-75.
27. M.K. Webster, L. Goya, A.C. Maiyar, G. L Firestone (1993) Characterization of Sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocrticoid and serum. Mol. Cell. Biol. 13:2031-2040.
28. A. Shigaev, C, Asher, H. Latter,H. Garty, E, Reuveny. (2000) Regulation of Sgk by aldosterone and its effects on the epithelial Na(+) channel. Am. J. Physiol
29. Liu D.; Yang, X.; Songyang, Z. Identification of CISK, a new member of the Sgk kinase family that promotes interleukina 3 dependent survival. Current Biol. (2000). 10(19) 1233-1236.
30. Leong, M.L.; Maiyar, A.C.; Kim, B.; O’Keefe B.A.; Firestone, G.L. (2003) Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells. J.Biol:Chem. 278 (8) 5871-5882.
31. Richards, J.S.; Scharma,S.C.; Falender, A.E.; Lo,Y.H. (2002).Expression of FKHD,FKHRL1, and AFX Genes in the rodent ovary: Evidence for regulation by IGF-1, Estrogen and the gonadotropins. Molecular Endocrinology 16(3):580-599.
32. Wu W, Chaudhuri S, Brickley DR, Pang D, Karrison T, Conzen SD ( 2004). Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells.Cancer Res. 64(5):1757-64.
33. Chung EJ, Sung YK, Farooq M, Kim Y, Im S, Tak WY, Hwang YJ, Kim YI, Han HS, Kim JC, Kim MK. Gene expression profile analysis in human carcinoma by cDNAmicroarray.Mol Cells. 2002 Dec 31;14(3):382-7.
34. Fillon S, Klingel K, Warntges S, Sauter M, Gabrysch S, Pestel S, Tanneur V, Waldegger S, Zipfel A, Viebahn R, Haussinger D, Broer S, Kandolf R, Lang F. Expression of the serine/threonine kinase hSGK1 in chronic viral hepatitis.CellPhysiolBiochem.2002;12(1):47-54.
35. Khani-Hanjani A. et al. Association between dinucleotide repeat in non-coding region of interferon-gamma gene and the susceptibility to, and severity of rheumatoid arthritis. The Lancet 356:820-825
36. Wilson AG, Julian A. Symons, Tarra T. Mcdowell, et al 1997. Duff Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation Proc. Natl. Acad. Sci. USA 94: 3195–3199,
37. Turner DM, Williams DM, Sankaran D, et al 1997. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet, 24: 1-8
38. Eskdale J, Gallagher G, Verweij CL et al 1998.Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc. Natl. Acad. Sci. USA 95: 9465–9470
39. MR Awad, A El-Gamel, P Hsleton et al 1998. Genotypic variation in the transforming growth factor beta 1 gene. Trasplantation 66: 1014-1020

Parole Chiave

GASTROENTEROLOGIA; IMMUNITA'; EPATOCARCINOMA; ESTROGENI; CELLULE DENDRITICHE; EPATITI VIRALI CRONICHE; PERITONITI BATTERICHE SPONTANEE; CITOCHINE